2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2691 | Oritavancin diphosphate | LY333328 diphosphate | Others , Antibacterial , Antibiotic |
Oritavancin diphosphate (LY333328 diphosphate) is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections. | |||
T37881 | Oritavancin(LY-333328) | ||
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro again... |